The Fresenius Medical Care (FMC) ST share was carefully examined by DZ Bank. The following results were determined.
DZ Bank has raised the fair value for FMC from 56 to 60 euros and left the classification on “buy”. The dialysis company exceeded expectations in the first quarter and despite a stressful flu season, Sven Kürten wrote in a study available on Monday. The annual outlook was confirmed and the debt relief is progressing. From 2026, the expert easily increased its estimates.
Between the course target and reality: the Fresenius Medical Care (FMC) ST share in detail on the day of the analysis
The Fresenius Medical Care (FMC) ST share was able to buy in Xetra trading at 4:03 p.m. and increased by 0.3 percent to EUR 50.52. Most recently, the owner changed the owner via Xetra 159,836 Fresenius Medical Care (FMC). The paper has increased by 14.4 percent since the beginning of 2025.
Frankfurt (dpa-afx analysis) / editorial finance.net
Publication of the original study: 12.05.2025 / 15:02 / mez for the first time passing on of the original study: 12.05.2025 / 15:05 / CET
Note: Information on the obligation to disclose the disclosure for conflicts of interest within the meaning of Section 85 (1) WPHG, Art. 20 VO (EU) 596/2014 For the Analysten House mentioned can be found at http://web.dpa-afx.de/offengegungs-
Selected leverage products on Fresenius Medical Care (FMC) St.
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Fresenius Medical Care (FMC) St.
The lever must be between 2 and 20
Advertising